Elizabeth Glaser Pediatric AIDS Foundation
Elizabeth Glaser Pediatric AIDS Foundation is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Elizabeth Glaser Pediatric AIDS Foundation.
Elizabeth Glaser Pediatric AIDS Foundation is a company.
Key people at Elizabeth Glaser Pediatric AIDS Foundation.
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is a nonprofit organization dedicated to ending HIV/AIDS in children, youth, and families through research, advocacy, global programs, and strengthening health systems.[1][3][4] Founded in 1988, EGPAF focuses on preventing mother-to-child transmission (MTCT) of HIV, providing treatment services, and integrating HIV care with family planning and reproductive health, operating in 12 countries primarily in Africa.[2][4][5] Key achievements include reducing U.S. pediatric HIV infections by 95%, protecting 4.4 million children via PMTCT programs, and supporting over 15,000 HIV service sites worldwide, with MTCT preventable 93% of the time through proper treatment.[1]
EGPAF's work emphasizes comprehensive responses: research into pediatric treatments, advocacy for funding and policy, and on-the-ground capacity building for governments and communities in high-burden regions.[2][3] It has cut global pediatric HIV infections by 50% and served over 33 million pregnant women with lifesaving services.[1]
EGPAF traces its roots to 1981, when Elizabeth Glaser contracted HIV via a blood transfusion during her daughter Ariel's birth, unknowingly transmitting it to Ariel through breastfeeding and later to her son Jake during pregnancy.[1][3][4] In 1985, Ariel's unexplained illnesses revealed advanced pediatric AIDS, for which no treatments existed; she died in 1988 despite the Glaser family's fight for AZT access, approved only for adults.[4]
Refusing defeat, Elizabeth co-founded the Pediatric AIDS Foundation in 1988 with friends Susan DeLaurentis and Susie Zeegen to fund research, raise awareness, and develop pediatric HIV drugs and MTCT prevention.[1][4] Elizabeth's 1992 Democratic National Convention speech criticized federal underfunding, amplifying the cause; her 1991 autobiography *In the Absence of Angels* shared their story.[4] She passed in 1994, prompting the foundation's renaming in her honor.[4] Over 35+ years, EGPAF has evolved from U.S.-focused advocacy to global leadership in pediatric AIDS elimination.[1][2]
While not a tech company, EGPAF leverages health technology innovations like diagnostics, telemedicine, and data systems to scale HIV services in low-resource settings, riding trends in digital health for global public health equity.[2][9] Its timing aligns with post-2020 gains in MTCT prevention amid ongoing challenges—10,000 weekly adolescent infections—positioning it to influence Universal Health Coverage via integrated HIV-family planning in Africa.[1][5] Market forces like donor funding, PEPFAR support, and tech-enabled tracking favor expansion, as EGPAF strengthens local systems and advocates for neglected pediatric needs, shaping ecosystems for scalable, tech-supported interventions.[7]
EGPAF is sharpening its singular goal: ending pediatric HIV/AIDS by intensifying expertise across children's health spectra, targeting millions untreated amid adolescent vulnerabilities.[1] Trends like AI-driven diagnostics, mRNA vaccines, and integrated telehealth will accelerate MTCT elimination and treatment access. Its influence may evolve toward tech-health hybrids, partnering with innovators for real-time data and prevention tools, sustaining Elizabeth's legacy of breakthroughs through focus—ensuring no child bears HIV's devastation.[1][7]
Key people at Elizabeth Glaser Pediatric AIDS Foundation.
